Cytochrome P-450 activity is differentially altered in severely injured patients

Objective:To assess whether changes in cytochrome P-450 (CYP) activity of specific CYP enzymes occur in severely injured patients and to assess changes in CYP activity during recovery. Design:Prospective clinical study. Setting:University-affiliated, level I trauma center and trauma critical care unit. Patients:Twenty-three multiply injured patients admitted to a trauma critical care unit were compared with healthy volunteers. Interventions:CYP metabolizing activity was assessed using the probe drugs mephenytoin (CYP-2C19), chlorzoxazone (CYP-2E1), dapsone (multiple CYP enzymes), and flurbiprofen (CYP-2C9). Measurements and Main Results:Mephenytoin metabolism was profoundly suppressed after injury and increased during postinjury recovery, whereas chlorzoxazone metabolism was suppressed to a lesser degree. Measures of dapsone and flurbiprofen metabolism were elevated throughout the study. Chlorzoxazone and mephenytoin metabolism correlated with the multiple organ dysfunction score and with the multiple organ failure score. Conclusions:CYP isoform activity is differentially altered by shock and trauma in injured patients. The metabolic activity of selected CYP isoforms may have potential for evaluating acute hepatic dysfunction in critically ill trauma patients.

[1]  A. Burstein,et al.  Cytochrome P450 3A4 activity after surgical stress , 2003, Critical Care Medicine.

[2]  U. de Faire,et al.  Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms. , 2002, Biochemical and biophysical research communications.

[3]  A. Peitzman,et al.  Hepatic dysfunction increases length of stay and risk of death after injury. , 2002, The Journal of trauma.

[4]  S. McGrath,et al.  The frequency and effects of cytochrome P450 (CYP) 2C9 polymorphisms in patients receiving warfarin. , 2002, Journal of the American College of Surgeons.

[5]  A. Peitzman,et al.  The Impact of Liver Dysfunction on Outcome in Patients with Multiple Injuries , 2001, The American surgeon.

[6]  T. Tracy,et al.  Sensitive and specific high-performance liquid chromatographic assay for 4'-hydroxyflurbiprofen and flurbiprofen in human urine and plasma. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[7]  E. Morgan,et al.  Down-regulation of the expression of three major rat liver cytochrome P450S by endotoxin in vivo occurs independently of nitric oxide production. , 1998, The Journal of pharmacology and experimental therapeutics.

[8]  H. Winn,et al.  Increases in metabolism of valproate and excretion of 6beta-hydroxycortisol in patients with traumatic brain injury. , 1998, British journal of clinical pharmacology.

[9]  R. Branch,et al.  Mephenytoin disposition and serum bile acids as indices of hepatic function in chronic viral hepatitis , 1997, Clinical pharmacology and therapeutics.

[10]  E. Morgan.  Regulation of cytochromes P450 during inflammation and infection. , 1997, Drug metabolism reviews.

[11]  R. Frye,et al.  Validation of the five‐drug “Pittsburgh cocktail” approach for assessment of selective regulation of drug‐metabolizing enzymes , 1997, Clinical pharmacology and therapeutics.

[12]  R. Frye,et al.  Determination of chlorzoxazone and 6-hydroxychlorzoxazone in human plasma and urine by high-performance liquid chromatography. , 1996, Journal of chromatography. B, Biomedical applications.

[13]  C. Sprung,et al.  Multiple Organ Dysfunction Score , 1996 .

[14]  G. Marchesini,et al.  The galactose elimination capacity test: a study of the technique based on the analysis of 868 measurements. , 1996, The American journal of gastroenterology.

[15]  C. Sprung,et al.  Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. , 1995, Critical care medicine.

[16]  K. Kudsk,et al.  Increased intestinal permeability following blunt and penetrating trauma. , 1995, Critical care medicine.

[17]  G. Regel,et al.  Monoethylglycinexylidide as an Early Predictor of Posttraumatic Multiple Organ Failure , 1995, Therapeutic drug monitoring.

[18]  M. Shapiro,et al.  MEGX (MONOETHYLGLYCINEXYLIDIDE): A NOVEL IN VIVO TEST TO MEASURE EARLY HEPATIC DYSFUNCTION AFTER HYPOVOLEMIC SHOCK , 1995, Shock.

[19]  T. Vales,et al.  Selective suppression of cytochrome P-450 gene expression by interleukins 1 and 6 in rat liver. , 1994, Biochimica et biophysica acta.

[20]  L. Corcos,et al.  Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. , 1993, Molecular pharmacology.

[21]  J. Singer,et al.  A simple multiple system organ failure scoring system predicts mortality of patients who have sepsis syndrome. , 1993, Chest.

[22]  J. Vincent,et al.  Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. , 1993, Chest.

[23]  W. Knaus,et al.  The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. , 1991, Chest.

[24]  T. Fabian,et al.  Effect of neurotrauma on hepatic drug clearance , 1991, Clinical pharmacology and therapeutics.

[25]  J. A. Porter,et al.  The contribution of N‐hydroxylation and acetylation to dapsone pharmacokinetics in normal subjects , 1990, Clinical pharmacology and therapeutics.

[26]  R. Branch,et al.  Scleroderma is associated with differences in individual routes of drug metabolism: A study with dapsone, debrisoquin, and mephenytoin , 1990, Clinical pharmacology and therapeutics.

[27]  J. Dasta,et al.  Physiologic Implications of Mechanical Ventilation on Pharmacokinetics , 1989, DICP : the annals of pharmacotherapy.

[28]  J. Gumucio,et al.  Hepatocyte heterogeneity: The coming of age from the description of a biological curiosity to a partial understanding of its physiological meaning and regulation , 1989, Hepatology.

[29]  T. Fabian,et al.  Phenytoin pharmacokinetics in critically ill trauma patients , 1988, Clinical pharmacology and therapeutics.

[30]  G. Matuschak,et al.  Organ interactions in the adult respiratory distress syndrome during sepsis. Role of the liver in host defense. , 1988, Chest.

[31]  J. Hassett,et al.  The pharmacokinetics of meperidine in acute trauma patients. , 1986, The Journal of trauma.

[32]  L. Griffeth,et al.  Effects of model traumatic injury on hepatic drug metabolism in the rat. III. Differential responses of cytochrome P-450 subpopulations. , 1984, Drug metabolism and disposition: the biological fate of chemicals.

[33]  A. M. Kholoussy,et al.  Prognostic significance of indocyanine green clearance in critically ill surgical patients , 1984, Critical care medicine.

[34]  J. Bircher.  Quantitative Assessment of Deranged Hepatic Function: A Missed Opportunity? , 1983, Seminars in liver disease.

[35]  J. Newell,et al.  Hepatic perfusion and splanchnic oxygen consumption in patients postinjury. , 1983, The Journal of trauma.

[36]  R. L. Fulton,et al.  Multiple system organ failure. The role of uncontrolled infection. , 1980, Archives of surgery.

[37]  D. McArthur,et al.  Multiple Organ Failure , 2000, Springer New York.

[38]  I. Singh,et al.  Cytochrome P-450 2E1 in rat liver peroxisomes: downregulation by ischemia/reperfusion-induced oxidative stress. , 1997, Free radical biology & medicine.

[39]  A. Sauaia,et al.  Early predictors of postinjury multiple organ failure. , 1994, Archives of surgery.